Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04916613
Title ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Unfit)
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors UNICANCER
Indications
Therapies
Age Groups: senior | adult
Covered Countries SWE | SVK | ROU | NLD | ITA | IRL | FRA | ESP | DEU | CHE | BEL


No variant requirements are available.